215 related articles for article (PubMed ID: 28454306)
1. Inhibitory effect of norcantharidin on melanoma tumor growth and vasculogenic mimicry by suppressing MMP-2 expression.
Wang Z; You D; Lu M; He Y; Yan S
Oncol Lett; 2017 Mar; 13(3):1660-1664. PubMed ID: 28454306
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
[TBL] [Abstract][Full Text] [Related]
3. Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP.
Zhu W; Sun W; Zhang JT; Liu ZY; Li XP; Fan YZ
Int J Oncol; 2015 Feb; 46(2):627-40. PubMed ID: 25405519
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
Wang H; Sun W; Zhang WZ; Ge CY; Zhang JT; Liu ZY; Fan YZ
PLoS One; 2014; 9(5):e96982. PubMed ID: 24811250
[TBL] [Abstract][Full Text] [Related]
5. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.
Hess AR; Seftor EA; Seftor RE; Hendrix MJ
Cancer Res; 2003 Aug; 63(16):4757-62. PubMed ID: 12941789
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
[TBL] [Abstract][Full Text] [Related]
8. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
9. Dual effects of collagenase-3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry.
Zhao X; Sun B; Li Y; Liu Y; Zhang D; Wang X; Gu Q; Zhao J; Dong X; Liu Z; Che N
Oncotarget; 2015 Apr; 6(11):8890-9. PubMed ID: 25749207
[TBL] [Abstract][Full Text] [Related]
10. Vasculogenic mimicry: current status and future prospects.
Zhang S; Zhang D; Sun B
Cancer Lett; 2007 Sep; 254(2):157-64. PubMed ID: 17306454
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
[TBL] [Abstract][Full Text] [Related]
13. A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.
Sun W; Fan YZ; Zhang WZ; Ge CY
J Exp Clin Cancer Res; 2011 Apr; 30(1):46. PubMed ID: 21529356
[TBL] [Abstract][Full Text] [Related]
14. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
15. CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
Martini C; DeNichilo M; King DP; Cockshell MP; Ebert B; Dale B; Ebert LM; Woods A; Bonder CS
BMC Cancer; 2021 Jul; 21(1):765. PubMed ID: 34215227
[TBL] [Abstract][Full Text] [Related]
16. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
[TBL] [Abstract][Full Text] [Related]
17. [The mechanisms of microenvironments influence on vasculogenic mimicry between intraocular and subcutaneous melanoma].
Chen LX; Sun BC; Zhang SW; He YJ; Li XR; He ZJ
Zhonghua Yan Ke Za Zhi; 2009 Jul; 45(7):641-6. PubMed ID: 19957694
[TBL] [Abstract][Full Text] [Related]
18. JQ1 effectively inhibits vasculogenic mimicry of pancreatic ductal adenocarcinoma cells via the ERK1/2-MMP-2/9 signaling pathway both in vitro and in vivo.
Zhuo M; Yuan C; Han T; Hu H; Cui J; Jiao F; Wang L
Am J Transl Res; 2019; 11(2):1030-1039. PubMed ID: 30899402
[TBL] [Abstract][Full Text] [Related]
19. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
